Supply Chain Logistics

Your supply chain may not be as ironclad as you think.

If you manufacture, distribute — or even reverse distribute — controlled substances, you shouldn’t underestimate your risk for drug diversion and abuse. The journey of the pill can be a long and winding one, with unsavory characters waiting in the shadows to do bad things with good shipments.

Today’s DEA rules and regulations are so complex, business owners and practitioners struggle to understand what they should be doing. Plus, the opioid crisis has resulted in more federal and state resources being put toward preventing drug diversion. And, the pressure is on investigators to step up controlled-substance compliance programs and conduct even tougher oversight.

Hefty civil fines are being levied against non-compliant individuals and businesses across the healthcare industry, including supply chain and logistics operations. Inspections conducted by the DEA and state agencies are typically unannounced, and the current federal fine per infraction is $14,502. But, it’s not uncommon for fines to exceed $1 million.

It can happen to you.

If you’re handling controlled substances in any way, you’re at risk for drug diversion. It’s imperative that you be prepared. Now is the time to investigate, identify, correct and strengthen your operation against the most common vulnerabilities you face today. Keeping up with changing standards, best practices, new requirements and growing threats are the most effective ways to protect your company. But failing to adapt to these new realities may not only cost you financially, it can also cause irreparable harm to your personal and professional reputation.

Don’t worry. We can help.

Assess your own risk.
Take the quiz.